Regeneron Pharmaceuticals (REGN) RSI Live Chart
Regeneron Pharmaceuticals (REGN) is trading around $961.65. Its daily RSI is 81.83, which is overbought, and its weekly RSI is 71.68 (overbought). The table below shows the live RSI on every timeframe.
Regeneron Pharmaceuticals RSI by timeframe
| Timeframe | RSI (14) | Signal |
|---|---|---|
| 30m | 69.23 | Neutral |
| 1h | 81.47 | Overbought |
| 1d | 81.83 | Overbought |
| 1w | 71.68 | Overbought |
| 1mo | 62.76 | Neutral |
Live, updates every few minutes. RSI period 14.
Regeneron Pharmaceuticals at a glance
- 1 week
- +19.04%
- 1 month
- +30.79%
- 3 months
- +26.43%
- 1 year
- +46.91%
- 52-week high
- $973.29
- 52-week low
- $591.65
- Market cap
- $101.55B#112 in the S&P 500
- In the S&P 500 since
- 2013
Regeneron Pharmaceuticals (REGN) is an S&P 500 company in the Health Care sector, classified under Biotechnology and headquartered in Tarrytown, New York. Founded in 1988, it has been in the index since 2013. By market cap it is the 112th largest company in the S&P 500 and the 19th largest of 60 in Health Care.
Over the past year REGN is up 46.9%, while the S&P 500 (SPY) is up 10.6%. It trades 1.2% below its 52-week high of $973.29 and 62.5% above its 52-week low of $591.65.
What the REGN RSI tells you
The Relative Strength Index (RSI) measures the speed and size of recent price moves on a scale from 0 to 100. It is one of the most widely used momentum indicators in stock trading.
A reading at or below 30 is considered oversold: selling may be overextended and a bounce more likely. A reading at or above 70 is overbought: buying may be stretched and a pullback more likely. Between 30 and 70 is neutral. Signals are strongest when several timeframes agree, which is why the table above shows Regeneron Pharmaceuticals on all of them at once.
RSI is a guide, not a guarantee. A stock can stay oversold or overbought for a long time in a strong trend. Traders usually combine it with divergences, volume and structure, all of which you can check on the live chart.